MedTrace Logo

Safety and Performance of the Journey™ II UNI Unicompartmental Knee System

NCT03768128 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 154

Last updated 2026-02-27

No results posted yet for this study

Summary

This clinical study will evaluate the early to midterm safety and performance of the JOURNEY™ II UNI UKS in patients with non-inflammatory degenerative joint disease of the knee requiring lateral or medial knee compartment replacement. Clinical, radiographic, health economic and safety outcomes will be evaluated.

Conditions

  • Non-inflammatory Degenerative Joint Disease (NIDJD) of the Knee

Interventions

DEVICE

Journey™ II UNI Unicompartmental Knee System

Journey™ II UNI UKS is a CE Marked medical device. The device has been designed to treat both medial and lateral unicompartmental disease. It is a comprehensive system designed to allow surgeons to perform UKA. It is comprised of the following anatomic components: Oxidized zirconium femoral components Titanium tibial components with a grit-blasted surface Polyethylene tibial insert components The device is asymmetric and is available in oxidized zirconium to reduce wear and increase implant longevity.

Sponsors & Collaborators

  • Smith & Nephew, Inc.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-10
Primary Completion
2025-05-19
Completion
2025-05-19

Countries

  • United States
  • Italy
  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03768128 on ClinicalTrials.gov